333 related articles for article (PubMed ID: 8506803)
21. [Hemodynamic study on erection induced by intracavernous injection of prostaglandin E1].
Watanabe H
Nihon Hinyokika Gakkai Zasshi; 1990 May; 81(5):732-8. PubMed ID: 2376930
[TBL] [Abstract][Full Text] [Related]
22. Penile scarring with intracavernous injection therapy using prostaglandin E1: a risk factor analysis.
Chen RN; Lakin MM; Montague DK; Ausmundson S
J Urol; 1996 Jan; 155(1):138-40. PubMed ID: 7490812
[TBL] [Abstract][Full Text] [Related]
23. Is there a role of radial rigidity in the evaluation of erectile dysfunction?
Ku JH; Song YS; Kim ME; Lee NK; Park YH
Int J Impot Res; 2001 Aug; 13(4):200-4. PubMed ID: 11494075
[TBL] [Abstract][Full Text] [Related]
24. Cavernous auto-injection therapy with prostaglandin E1.
Nisén H
Ann Chir Gynaecol Suppl; 1993; 206():69-73. PubMed ID: 8291874
[TBL] [Abstract][Full Text] [Related]
25. [Clinical evaluation of intracavernous self-injection of vasoactive drugs for impotence: a long-term follow-up observation].
Hayashi S; Iwai Y; Yasumoto R; Matsuda J; Kawano M; Omachi T; Kono T; Yamamoto S; Sakakura T; Minami H
Hinyokika Kiyo; 1994 Jan; 40(1):37-41. PubMed ID: 7509119
[TBL] [Abstract][Full Text] [Related]
26. Intracavernous injection of prostaglandin E1 for the treatment of erectile impotence.
Ishii N; Watanabe H; Irisawa C; Kikuchi Y; Kubota Y; Kawamura S; Suzuki K; Chiba R; Tokiwa M; Shirai M
J Urol; 1989 Feb; 141(2):323-5. PubMed ID: 2913354
[TBL] [Abstract][Full Text] [Related]
27. Use of intracavernous injection of prostaglandin E1 for neuropathic erectile dysfunction.
Hirsch IH; Smith RL; Chancellor MB; Bagley DH; Carsello J; Staas WE
Paraplegia; 1994 Oct; 32(10):661-4. PubMed ID: 7831071
[TBL] [Abstract][Full Text] [Related]
28. [Response to intracavernous administration of 3 different drugs in the same group of patients with erectile dysfunction].
Ribé N; Rajmil O; Bassas L; Jurado C; Pomerol JM
Arch Esp Urol; 2001 May; 54(4):355-9. PubMed ID: 11455770
[TBL] [Abstract][Full Text] [Related]
29. Use of prostaglandin E1 in the treatment of sexual impotence after heart transplantation: initial clinical experience.
Livi U; Faggian G; Sorbara C; Gambino A; Calabrò A; Artibani W; Bortolotti U; Pagano F
J Heart Lung Transplant; 1993; 12(3):484-6. PubMed ID: 8329422
[TBL] [Abstract][Full Text] [Related]
30. [The use of PGE1 in the treatment of erectile deficiency].
Arena F; Peracchia G; Di Stefano C; Cortellini P
Acta Biomed Ateneo Parmense; 1996; 67(1-2):49-53. PubMed ID: 10021734
[TBL] [Abstract][Full Text] [Related]
31. [Echo-Doppler duplex combined with intracavernous injection of prostaglandin E1 in the diagnosis of impotence].
Moncada Iribarren I; Concejo J; Escribano Patiño G; Verdú Tartajo F; Díez Cordero JM; Herranz Amo F; Jara Rascon J; Basquero González B; Martin Martínez JC; Hernández Fernández C
Arch Esp Urol; 1992; 45(1):45-51. PubMed ID: 1586215
[TBL] [Abstract][Full Text] [Related]
32. Office treatment: intracavernous injections of prostaglandin E1 (PG E1) and improvement of spontaneous erections.
Beretta G; Marzotto M; Zanollo A; Re B
Acta Eur Fertil; 1991; 22(4):221-3. PubMed ID: 1844326
[TBL] [Abstract][Full Text] [Related]
33. Intracavernous self-injection of prostaglandin E1 in the therapy of erectile dysfunction.
Porst H; van Ahlen H; Block T; Halbig W; Hautmann R; Löchner-Ernst D; Rudnick J; Staehler G; Weber HM; Weidner W
Vasa Suppl; 1989; 28():50-6. PubMed ID: 2609244
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of prostaglandin E1 and its main metabolites after intracavernous injection and short-term infusion of prostaglandin E1 in patients with erectile dysfunction.
Cawello W; Schweer H; Dietrich B; Seyberth HW; Albrecht D; Fox A; Hohmuth H
J Urol; 1997 Oct; 158(4):1403-7. PubMed ID: 9302131
[TBL] [Abstract][Full Text] [Related]
35. [Intracavernous injection test by prostaglandin E1].
Otani T
Nihon Rinsho; 2002 Jun; 60 Suppl 6():173-7. PubMed ID: 12166133
[No Abstract] [Full Text] [Related]
36. Comparison of penile vascular effect induced by intracavernous injection of papaverine and prostaglandin E1.
Hwang TI; Lue TF; Yang CR; Chang CL; Chang CH; Wu HC
Taiwan Yi Xue Hui Za Zhi; 1989 Oct; 88(10):1038-41. PubMed ID: 2634727
[TBL] [Abstract][Full Text] [Related]
37. [The therapeutic and diagnostic potentials of the intra-corpora cavernosa use of alprostadil, Edex, in patients with erectile dysfunction].
Mzo EB; Dmitriev DG
Ter Arkh; 1995; 67(10):45-8. PubMed ID: 8779105
[TBL] [Abstract][Full Text] [Related]
38. [Long-term results of the treatment with intracavernous injection of vasoactive drugs].
Rodríguez Vela L; Gonzalvo Ibarra A; Gil Martínez P; Benejan Gual J; Cuesta Presedo JM; Ríoja Sanz LA
Arch Esp Urol; 1996 Apr; 49(3):257-69. PubMed ID: 8702347
[TBL] [Abstract][Full Text] [Related]
39. Intracavernous prostaglandin E1 in erectile dysfunction.
Linet OI; Neff LL
Clin Investig; 1994 Jan; 72(2):139-49. PubMed ID: 8186662
[TBL] [Abstract][Full Text] [Related]
40. Anxiety-induced failure in erectile response to intracorporeal prostaglandin-E1 in non-organic male impotence: a new diagnostic approach.
Aversa A; Rocchietti-March M; Caprio M; Giannini D; Isidori A; Fabbri A
Int J Androl; 1996 Oct; 19(5):307-13. PubMed ID: 8985780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
